Nations Financial Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
5,083
+89
+2% +$17.5K 0.05% 360
2026
Q1
$979K Hold
4,994
0.05% 370
2025
Q4
$867K Buy
4,994
+404
+9% +$73.6K 0.05% 386
2025
Q3
$875K Buy
4,590
+276
+6% +$49K 0.05% 354
2025
Q2
$775K Buy
4,314
+564
+15% +$98K 0.05% 349
2025
Q1
$635K Sell
3,750
-511
-12% -$83.9K 0.05% 370
2024
Q4
$643K Sell
4,261
-4
-0.1% -$622 0.05% 377
2024
Q3
$662K Buy
4,265
+679
+19% +$101K 0.05% 374
2024
Q2
$491K Buy
3,586
+222
+7% +$30.4K 0.04% 408
2024
Q1
$448K Buy
3,364
+517
+18% +$67.1K 0.04% 435
2023
Q4
$393K Buy
2,847
+10
+0.4% +$1.31K 0.04% 449
2023
Q3
$346K Buy
2,837
+92
+3% +$12.3K 0.03% 465
2023
Q2
$386K Buy
2,745
+322
+13% +$44.4K 0.04% 438
2023
Q1
$343K Buy
2,423
+737
+44% +$105K 0.04% 458
2022
Q4
$264K Buy
+1,686
New +$242K 0.03% 497

Other funds holding DGX

Nations Financial Group's DGX Position: Q2 2026 in Review

Nations Financial Group increased its Quest Diagnostics (DGX) stake by 1.8% in Q2 2026, buying an estimated $17.5K and bringing the position to 5,083 shares worth $1.08M. The position accounts for 0.05% of the portfolio, ranked #360.

Nations Financial Group first reported a position in DGX in Q4 2022 and has held it in 15 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Nations Financial Group held 5,083 shares of Quest Diagnostics worth $1.08M as of Q2 2026.
  • Nations Financial Group bought 89 Quest Diagnostics shares in Q2 2026, an estimated $17.5K.
  • Quest Diagnostics made up 0.05% of Nations Financial Group's portfolio in Q2 2026, its #360 holding.
  • Nations Financial Group first reported a position in Quest Diagnostics in Q4 2022 and has held it in 15 quarters since.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.